全球婴儿营养低聚糖市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

婴儿营养品中的低聚糖市场分析

随着人们越来越意识到这些生物活性化合物的健康益处，婴儿营养品市场中的低聚糖正在经历显著增长。低聚糖主要存在于人类母乳中，对婴儿肠道健康、免疫力和整体发育至关重要。随着全球母乳喂养率的差异以及对高质量婴儿配方奶粉的需求不断增加，制造商正在加入低聚糖以紧密模仿母乳的营养成分。低聚糖生产技术的进步和支持性监管框架进一步促进了市场增长。

婴儿营养中的寡糖市场规模

2023 年全球婴儿营养中的寡糖市场规模价值 2.1619 亿美元，预计到 2031 年将达到 3.6594 亿美元，在 2024 年至 2031 年的预测期内复合年增长率为 9.0%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解之外，Data Bridge Market Research 策划的市场报告还包括深入的专家分析、按地理代表的公司生产和产能、分销商和合作伙伴的网络布局、详细和更新的价格趋势分析以及供应链和需求的缺口分析。

报告范围和市场细分       

婴儿营养中的寡糖市场定义

Oligosaccharides in infant nutrition refer to complex carbohydrates composed of short chains of sugar molecules, which are naturally found in human breast milk and are essential for the growth and development of infants. These bioactive compounds play a crucial role in promoting gut health by acting as prebiotics, stimulating the growth of beneficial gut bacteria. Oligosaccharides support the development of the immune system and may help protect against infections by preventing the adhesion of harmful pathogens to the gut lining.

Oligosaccharides in Infant Nutrition Market Dynamics

Drivers

• Growing Awareness of Infant Health    

Parents today are more informed about the critical role of early nutrition in their children's development. They seek products that can offer the closest possible match to the benefits of natural breastfeeding. Oligosaccharides, known for their role in promoting gut health and boosting the immune system, are becoming a key ingredient in premium infant formulas. This growing awareness is pushing manufacturers to incorporate these beneficial compounds, thus expanding the market for oligosaccharides in infant nutrition. Increasing awareness among parents about the importance of infant health and nutrition is driving the demand for oligosaccharides in infant formulas.       

• Rising Demand for Breastfeeding Alternatives           

As breastfeeding rates fluctuate globally, there is a higher demand for infant formulas that closely replicate the benefits of human breast milk, including the addition of oligosaccharides. Many mothers are unable to breastfeed due to medical, personal, or professional reasons, leading them to seek alternatives that can provide similar nutritional benefits. Infant formulas enriched with oligosaccharides offer a solution by mimicking the prebiotic effects found in human milk, promoting better digestive health and immune function in infants. This increasing reliance on high-quality formula products is significantly driving the oligosaccharides market.

Opportunities

• Technological Advancements in Incorporation of Oligosaccharides  

Innovations in the production and incorporation of oligosaccharides into infant nutrition products are enhancing their availability and effectiveness. Advances in biotechnology and food science have enabled the efficient extraction and synthesis of oligosaccharides, making them more accessible for use in infant formulas. These technological breakthroughs are not only improving the quality and efficacy of the products but also reducing production costs over time. This progress opens up new opportunities for manufacturers to develop and market a broader range of oligosaccharide-enriched infant nutrition products, creating new opportunities for growing consumer demand for advanced nutritional solutions.   

• Increasing Disposable Incomes      

Higher disposable incomes, particularly in emerging economies, are enabling consumers to spend more on premium infant nutrition products. As economies grow and living standards rise, parents in these regions are more willing and able to invest in high-quality nutrition for their infants. This trend is driving the demand for specialized and enriched formulas, including those containing oligosaccharides. The increasing purchasing power allows more consumers to opt for products that offer superior health benefits, thereby creating new opportunities for the market for oligosaccharides in infant nutrition.

Restraints/Challenges

• High Production Costs

The complex process of producing oligosaccharides can be expensive, potentially limiting their affordability and widespread use in infant nutrition. The production of oligosaccharides involves advanced biotechnological processes and stringent quality control measures, which contribute to high manufacturing costs. These expenses are often passed on to consumers, making oligosaccharide-enriched formulas more costly than standard options. This cost barrier can limit market growth, especially in price-sensitive regions where consumers may opt for more affordable alternatives.

• Limited Awareness in Developing Regions

In some developing regions, there is still limited awareness about the benefits of oligosaccharides in infant nutrition, which can slow market penetration. Despite the known health advantages, many parents and healthcare providers in these areas are not fully informed about the role of oligosaccharides in promoting gut health and boosting immunity. This lack of knowledge can hinder the adoption of oligosaccharides in nutrition.

Top of Form

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

除了标准报告外，我们还提供从预测的运输延迟、按区域划分的分销商映射、商品分析、生产分析、价格映射趋势、采购、类别绩效分析、供应链风险管理解决方案、高级基准测试等角度对采购层面的深入分析，以及其他采购和战略支持服务。

经济放缓对产品定价和供应的预期影响

当经济活动放缓时，行业开始受到影响。DBMR 提供的市场洞察报告和情报服务考虑了经济衰退对产品定价和可获得性的预测影响。借助这些，我们的客户通常可以领先竞争对手一步，预测他们的销售额和收入，并估算他们的盈亏支出。

婴幼儿营养品寡糖市场最新动态

• 2023 年 11 月，雀巢宣布在中国大陆推出以惠氏启赋品牌推出的以母乳低聚糖 (HMO) 为主要成分的科学成长奶粉解决方案，用于早期生命营养。此次推出是在中国国家卫生健康委员会最近批准使用这些生物活性成分之后推出的
• 2020 年 11 月，雅培推出了迄今为止最具创新性的婴儿配方奶粉 Similac Pro-Advance，该配方含有 2'-岩藻糖基乳糖寡糖 (2'-FL)，这是加拿大首款在婴儿配方奶粉中采用这种突破性成分的产品

婴儿营养中的寡糖市场范围

市场根据类型和应用进行细分。这些细分市场之间的增长情况将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 低聚半乳糖
• 母乳低聚糖
• 低聚果糖

应用

• 食物
• 健康产品
• 饮料
• 药品
• 其他的

婴儿营养品中的寡糖市场区域分析

对市场进行了分析，并按上述国家、类型和应用提供了市场规模见解和趋势。

市场覆盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷以及南美洲其他地区。

由于中国、印度和日本等国家人口的可支配收入不断增加，北美预计将占据市场主导地位。随着经济状况的改善，这些地区的更多父母能够买得起优质婴儿营养产品，包括富含寡糖的产品。       

亚太地区预计将出现显著增长，因为对创新和高品质营养产品的需求不断增长，包括用于生产食品和糖果的偶尔卡路里甜味剂。该地区完善的医疗保健基础设施、较高的消费者意识以及领先婴儿营养公司的强大市场占有率促成了这一趋势。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。

婴儿营养品中的寡糖市场份额

市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

在市场上运营的一些主要市场参与者包括：

• 雅培（美国）
• 杜邦营养与健康（美国）
• FrieslandCampina Domo（荷兰）
• Ingredion (美国)
• Carbosynth（英国）
• Dairy Crest（英国）
• Inbiose（比利时）
• Jennewein Biotechnologie（德国）
• Tereos（法国）
• ZuChem (美国)
• Elicityl（法国）
• Dextra（英国）

SKU-23105